The Twenty-Fifth  by Kligman, Albert M.
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, 67 :1, 1976 
Copyright © 1976 by The Williams & Wilkins Co. 
The Twenty-Fifth 
VoL 67, No.1 
Print ed in U.S.A . 
PREFACE 
Twenty-five years ago, an event occurred at the Arnold Laboratories of Brown University in 
Providence, Rhode Island, which was to have a profound influence on the culture of 
dermatology. 
A biologist with a keen interest in the anatomy of skin, Dr. William Montagna, brought 
together a small group of young academicians who were beginning to sense that the 
integument 'was a structure of great beauty and interest apart from the distresses it 
occasioned when diseased. Every physician at that informal convocation caught skin fever 
from Montagna, a delirium which could only be moderated by rushing back to the 
laboratories to seek revelations which could be delivered to co-religionists at the next meet-
ing. Every year since then, a revival meeting has been held under the passionate and inspired 
leadership of Bill Montagna, now appropriately known as the "Prince of Primates." The 
volumes issuing from the Annual Symposia on the Biology of Skin comprise a substantive 
record of the great advances in our knowledge of the structure and function of skin. 
It is impossible to overstate Montagna's towering contribution to the science of skin. His 
uncountable lectures, papers, and books, all stamped by an inimitable, all-captivating, 
personal style, have influenced all who have seriously labored as teachers, thinkers, and 
workers in the field of cutaneous research. Montagna is a genius in the great tradition of his 
scientific forebears-Malpighi , Scarpa, Golgi, Corti, and other immortal Italians. 
The 25th Symposium on the Biology of Skin was made possible by generous contributions 
from: Amerchol; American Academy of Dermatology, Inc.; Amway Corporation; August C. 
Stiefel Research Institute, Inc.; Avon Products Foundation, Inc.; Bristol-Myers Products; 
Burroughs Wellcome Company; Calgon Consumer Products Company, Inc., Carter Products; 
Chesebrough-Pond's Inc.; Colgate-Palmolive Company; Delbay Pharmaceuticals, Inc.; 
Derm-Arts Laboratories; Dermatology Foundation; Dermik Laboratories, Inc.; The Gillette 
Company; G. S. Herbert Laboratories; Helena Rube·nstein; Hoffman-La Roche, Inc.; 
Hoechst Pharmaceuticals, Inc.; Johnson & Johnson; Johnson & Johnson Baby Products Co.; 
The Kroc Foundation; Lever Brothers Company; Lila Gruber Research Foundation; Menley 
& James Laboratories; Orentreich Medical Group; Owen Laboratories; The Procter & 
Gamble Company; Schering Corporation; Smith Kline & French Laboratories; The Society 
for Investigative Dermatology, Inc.; The Squibb Institute for Medical Research; Syntex; 
Texas Pharmacal Company; The Upjohn Company; Vick Divisions Research; Warner-Lam-
bert Research Institute; Westwood Pharmaceuticals Inc. 
Major support for the Symposium was provided by the National Institute of Arthritis, 
Metabolism, and Digestive Diseases (Research Grant 5 R13 AM09431-10) and the Medical 
Research Foundation of Oregon. 
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